Gene · 871
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection. | Pharmaceutics | 2022 | 35745708 | PubTator, text mining | PubMed |
| Identification of Angiogenic Cargoes in Human Fibroblasts-Derived Extracellular Vesicles and Induction of Wound Healing. | Pharmaceuticals (Basel) | 2022 | 35745621 | PubTator, text mining | PubMed |
| Role and Function of Mesenchymal Stem Cells on Fibroblast in Cutaneous Wound Healing. | Biomedicines | 2022 | 35740413 | PubTator, text mining | PubMed |
| KDEL Receptors: Pathophysiological Functions, Therapeutic Options, and Biotechnological Opportunities. | Biomedicines | 2022 | 35740256 | PubTator, text mining | PubMed |
| Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer. | BMC Cancer | 2022 | 35739492 | PubTator, text mining | PubMed |
| Effects of Coronary Artery Disease-Associated Variants on Vascular Smooth Muscle Cells. | Circulation | 2022 | 35735005 | PubTator, text mining | PubMed |
| Real-World Data and Budget Impact Analysis (BIA): Evaluation of a Targeted Next-Generation Sequencing Diagnostic Approach in Two Orthopedic Rare Diseases. | Front Pharmacol | 2022 | 35734413 | PubTator, text mining | PubMed |
| Cbp1, a fungal virulence factor under positive selection, forms an effector complex that drives macrophage lysis. | PLoS Pathog | 2022 | 35731824 | PubTator, text mining | PubMed |
| Phage-Related Ribosomal Protease (Prp) of Staphylococcus aureus: In Vitro Michaelis-Menten Kinetics, Screening for Inhibitors, and Crystal Structure of a Covalent Inhibition Product Complex. | Biochemistry | 2022 | 35731716 | PubTator, text mining | PubMed |
| H3K27ac-activated lncRNA KTN1-AS1 aggravates tumor progression by miR-505-3p/ZNF326 axis in ovarian cancer. | Ann Transl Med | 2022 | 35722429 | PubTator, text mining | PubMed |
| A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma. | Evid Based Complement Alternat Med | 2022 | 35722147 | PubTator, text mining | PubMed |
| Cardiac fibroblast sub-types in vitro reflect pathological cardiac remodeling in vivo. | Matrix Biol Plus | 2022 | 35719864 | PubTator, text mining | PubMed |
| GLUT1 Regulates the Tumor Immune Microenvironment and Promotes Tumor Metastasis in Pancreatic Adenocarcinoma via ncRNA-mediated Network. | J Cancer | 2022 | 35711842 | PubTator, text mining | PubMed |
| Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis. | Arch Toxicol | 2022 | 35708773 | PubTator, text mining | PubMed |
| An Unusual Diagnosis of Sporadic Type III Osteogenesis Imperfecta in the First Day of Life. | Case Rep Pediatr | 2022 | 35706981 | PubTator, text mining | PubMed |
| The power of heteronemin in cancers. | J Biomed Sci | 2022 | 35705962 | PubTator, text mining | PubMed |
| Inter-donor variability of extracellular matrix production in long-term cultures of human fibroblasts. | Biomater Sci | 2022 | 35700514 | PubTator, text mining | PubMed |
| Forcing the Antitumor Effects of HSPs Using a Modulated Electric Field. | Cells | 2022 | 35681533 | PubTator, text mining | PubMed |
| Multi-Epitope Protein as a Tool of Serological Diagnostic Development for HTLV-1 and HTLV-2 Infections. | Front Public Health | 2022 | 35677763 | PubTator, text mining | PubMed |
| Cell fate roadmap of human primed-to-naive transition reveals preimplantation cell lineage signatures. | Nat Commun | 2022 | 35672317 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/papers?page=34